FAREVA’s Post

🌟 Spotlight on QYOBO in Welt am Sonntag's Easter Edition! 🎉 We're thrilled to be featured in one of Germany's top news outlets, showcasing how #QYOBO's innovative approach revolutionizes the use of data in the global #pharmaceutical market. 💡 "Dem Mangel auf der Spur - Tracing Shortages": Learn how the QYOBO platform offers unparalleled insights into the #pharmaceuticalsupplychain and makes a difference in addressing global #drugshortages. Plus, don't miss the perspective of Bork Bretthauer from Pro Generika, underlining the impact of #QYOBO within the generic pharmaceutical sector. 🙏 A huge thanks to Andreas Macho for his in-depth coverage, highlighting our transformative work in the pharmaceutical industry. #Innovation #GlobalShortages #SupplyChainSolutions #WeltAmSonntag

A2 Healthcare is among the top CROs that dominate the Japanese market, with their market share continuing to grow as reported by the European Pharmaceutical Review in 2020. Researchers emphasize that outsourcing research facilities will play a key role in the clinical trial space, with major CROs exercising their power to choose clients. Having increased its presence in the United States, A2 is rapidly becoming a leading Japanese CRO with global reach to meet the need for wider capability. Visit the website to learn more about A2 Healthcare's vision. https://lnkd.in/ghJHJKrk #JapaneseCRO #Pharmaceutical #Biotech #PipelineAccelerator #BostonBiotech #PharmaInnovation #DrugDevelopment #DrugDiscovery

𝐔𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐂𝐚𝐩𝐬𝐮𝐥𝐞𝐬 𝐏𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥: 𝐄𝐱𝐩𝐞𝐝𝐢𝐭𝐢𝐧𝐠 𝐃𝐫𝐮𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐢𝐧 𝐚 𝐅𝐚𝐬𝐭-𝐌𝐨𝐯𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 In the dynamic landscape of pharmaceutical innovation, capsules emerge as a game-changer. Authored by Oliver Cram, Catherine K. Markopoulou, Dr.Jnanadeva Bhat and Manali Dalvi latest article dives deep into how capsules are revolutionizing drug development. As a preferred choice in the industry, capsules simplify the process, reduce time constraints, and cut down on resource burdens, paving the way for faster market readiness. Explore how capsules enhance efficiency and cost-effectiveness, making them indispensable in the journey of new drug entities from research to market. Discover the myriad benefits they offer in meeting the ever-growing demands of the 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐬𝐞𝐜𝐭𝐨𝐫. 🔗 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/g8Xb-9RS 🔗 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐞-𝐛𝐨𝐨𝐤 𝐧𝐨𝐰: https://lnkd.in/gv7R4SPi #PharmaceuticalInnovation #DrugDevelopment #CapsulesInPharma #BiotechAdvancements #PharmaTrends #LifeSciences #Pharmaceuticals #Biotechnology #HealthcareInnovation #PharmaResearch #DrugDiscovery #PharmaIndustry #CapsuleTechnology #MedicalResearch #HealthcareSolutions

I invite you to read our new article and explore how the capsules technology is poised to make a significant impact on drug development. #ACGCapsules #capsuletechnology #drugdevelopment

The development of Regadenoson offers a look at both the risks and rewards involved in bringing a new pharmaceutical to market. Learn about the science, challenges, and breakthroughs behind this new drug. 💊✨ Dive into the world of pharmaceutical innovation! #PharmaNews #DrugDevelopment #HealthcareInnovation Watch the full video: https://lnkd.in/epTv3hPJ

Hey, connections..!! I have attended the 2nd international conference "Pharmaceutical Research Fundamentals and Advanced Trends" Organised by the Indian Pharmaceutical Association Kolhapur Locak Branch. It was an amazing experience to understand the new and innovative research trends going on all over the world. #pharma #international #research #F&D #advanced trends

"The complexity of drugs and their delivery has been increasing over the past few decades. Combined with a growing prevalence of chronic illnesses, this market evolution is putting more pressure on pharmaceutical manufacturers to develop novel therapies that might also have unique formulation needs.” My colleague Peter Droc, Head of Drug Product Services at Lonza, recently shared his thoughts on the solutions to increasingly complex formulation needs, and how these can ensure quality and patient safety, while also decreasing time-to-market. Read the full article here: https://lnkd.in/erq2pDYW #AHealthierWorld #DrugProduct #LonzaDPS

"The complexity of drugs and their delivery has been increasing over the past few decades. Combined with a growing prevalence of chronic illnesses, this market evolution is putting more pressure on pharmaceutical manufacturers to develop novel therapies that might also have unique formulation needs.” My colleague Peter Droc, Head of Drug Product Services at Lonza, recently shared his thoughts on the solutions to increasingly complex formulation needs, and how these can ensure quality and patient safety, while also decreasing time-to-market. Read the full article here: https://lnkd.in/eV3EG7si #AHealthierWorld #DrugProduct #LonzaDPS

"The complexity of drugs and their delivery has been increasing over the past few decades. Combined with a growing prevalence of chronic illnesses, this market evolution is putting more pressure on pharmaceutical manufacturers to develop novel therapies that might also have unique formulation needs.” My colleague Peter Droc, Head of Drug Product Services at Lonza, recently shared his thoughts on the solutions to increasingly complex formulation needs, and how these can ensure quality and patient safety, while also decreasing time-to-market. Read the full article here: https://lnkd.in/gb-YD2zS #AHealthierWorld #DrugProduct #LonzaDPS

📢 Exciting News! The October 2024 edition of Chemical Today Digital Magazine is Now Live! 🌐 This month, we’re diving into the Pharmaceutical Industry, highlighting the latest innovations, key trends, and expert insights that are driving the future of pharma. 💊✨ Don’t miss out—click the link below to read the Magazine! 👇 https://lnkd.in/g_fjKMUu To subscribe Digital Magazine https://lnkd.in/gSeMg-Ut #ChemicalToday #PharmaceuticalFocus #October2024Issue #PharmaInnovation #DigitalMagazine #IndustryInsights #pharmaindustry #pharmaceutical #chemicals #academics #worldofchemicals